Acura Pharmaceuticals, Inc. Restructures Debt Obligations

Wednesday, 10 Oct 2018 

Oct 9 (Reuters) - Acura Pharmaceuticals Inc ::ACURA PHARMACEUTICALS, INC. RESTRUCTURES DEBT OBLIGATIONS.ACURA PHARMACEUTICALS - PER TERMS OF SCHUTTE'S DEBT, AFTER RETIREMENT OF OXFORD FINANCE DEBT, CO TO GRANT HIM SECURITY INTEREST IN ITS ASSETS.ACURA PHARMACEUTICALS INC - ON OCT 5, RESTRUCTURED DEBT OBLIGATIONS BY RECEIVING AN ADDITIONAL $1.8 MILLION LOAN FROM JOHN SCHUTTE.ACURA PHARMACEUTICALS INC - RESTRUCTURED DEBT OBLIGATIONS BY ALSO RETIRING IN FULL SENIOR SECURED DEBT WITH OXFORD FINANCE FOR PAYMENT OF $1.5 MILLION.ACURA PHARMACEUTICALS - BALANCE OF SCHUTTE'S LOAN WILL EXTEND OPERATIONS INTO NOV 2018 WHILE CO REMAINS FOCUSED ON LICENSING ITS LEAD ASSET LTX-03.  > Full Article

Source : https://in.reuters.com/finance/stocks/ACUR.PK/key-developments

Thanks for visit my website
Acura Pharmaceuticals Inc (ACUR.PK)
Acura Pharmaceuticals, Inc. Secures Bridge Funding
Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2018 Investor Update
Savient Pharmaceuticals: Glimmers Of Hope?
Urigen Pharmaceuticals Announces Results of Shareholder Meeting Vote on Proposed Restructuring
Novelion Therapeutics Subsidiary Enters Into Licensing Agreement for JUXTAPID in Japan Nasdaq:NVLN
India Inc sews deals worth $60 billion in 2017 with big M&As
A Clean Bill Of Health Gets Valeant Pharmaceuticals An Investment Grade Rating
UPDATE 1-Epix Pharma to go bankrupt if debt restructuring fails